Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Genprex Inc
GNPX
Healthcare
Biotechnology
Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on the development of gene-based therapies for patients with unmet medical needs. The Company's lead oncology drug candidate, REQORSA Immunogen therapy drug (quaratusugene ozeplasmid), is being developed to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The active agent in REQORSA is a...
plasmid that expresses a tumor suppressor gene named TUSC2. REQORSA consists of the TUSC2 gene-expressing plasmid encapsulated in non-viral nanoparticles made from lipid molecules (its ONCOPREX Nanoparticle Delivery System). The Company is also using a different gene therapy delivery system in developing its pre-clinical diabetes candidates, GPX-002 and GPX-003. Its diabetes gene therapy is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:GNPX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 05, 2024 9:29am
GNPX....P.O set up
Go ahead ...I dare ya....$8
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Feb 01, 2024 2:07pm
RE:GNPX....Announces 1-for-40 Reverse Stock Split Eff 02/02/24
So there's a little less than 2 hrs left til the close...just curious if there is anyone out there that would like to make a comment on this situation Feel free to chime in with any useful
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 31, 2024 12:53pm
GNPX....Announces 1-for-40 Reverse Stock Split Eff 02/02/24
2024-01-31 05:42 ET - News Release AUSTIN, Texas, Jan. 31, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage
...more
(91)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 05, 2024 4:00pm
Genprex Provides Business Update and Outlook for 2024
Just In: $GNPX Genprex Provides Business Update and Outlook for 2024Genprex Provides Business Update and Outlook for 2024 PR Newswire Acclaim-1 Phase 2a and Acclaim-3 Phase 1 clinical studies opening
...more
(28)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Jun 29, 2023 8:08pm
Update on GNPX
https://youtu.be/-4fxhYpCBYM
(28)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Jun 01, 2023 9:10am
And supporting report!
https://themarketnewsreport.com/this-gene-therapy-stock-360-potential-upside/?utm_source=mcnalliemoney&utm_medium=influencer&utm_campaign=gnpx
(28)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Jun 01, 2023 9:02am
Excellent YT analysis on Genprex!
https://youtu.be/J6WR-1NoE-s
(131)
•••
sylvain_007
X
View Profile
View Bullboard History
Post by
sylvain_007
on Jan 05, 2023 9:16am
Is GNPX can found the miraculous therapy?
I hope for every one who has affected by diabet i or 2, if this therapy have results like the research showed, it is a good candidate for a buyout.
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Jan 03, 2022 8:29pm
GNPX - Easy Money Rundown
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Jan 03, 2022 5:44pm
GNPX - Isn't Done Running, Home Run Play
(9)
•••
schoolofrock
X
View Profile
View Bullboard History
Post by
schoolofrock
on Sep 10, 2020 10:32am
Genprex CEO Rodney Varner exclusive corporate presentation
Genprex CEO Rodney Varner exclusive corporate presentation. Tune in, no charge, 1pm EDT https://attendee.gotowebinar.com/register/3838700065873891088
(142)
•••
Impalaman
X
View Profile
View Bullboard History
Comment by
Impalaman
on Jun 24, 2020 10:57am
RE:I feel a big jump coming---25th---june
A big flag formation on the weekly chart --is ready to fly up--and don't for get after friday close --they go into the Russell 300---so big buying starting to come in today and most likely next
...more
(142)
•••
Impalaman
X
View Profile
View Bullboard History
Post by
Impalaman
on Jun 24, 2020 10:46am
I feel a big jump coming---25th---june
Thursday morning----could be back in the 5-6 dollar range again very soon.
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market